Veracyte, Rosetta Genomics, NanoString Lead Decliners as Life Science Tools/Omics Stocks Decline in April | GenomeWeb

NEW YORK (GenomeWeb) – Veracyte, Rosetta Genomics, and NanoString Technologies led a lineup of firms in the GenomeWeb Daily News Index that saw their share prices retreat in April, as the Index took a 5 percent hit during the month.

Overall, stocks for 22 of the 29 companies in the Index dropped in April with Veracyte (-25 percent), Rosetta Genomics (-24 percent), and NanoString (-21 percent) pacing the decliners. The gainers were led by Myriad Genetics (+23 percent) and Sequenom (+11 percent) as the only two firms with double-digit percentage increases in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.